Your session is about to expire
← Back to Search
Guanfacine for Alcohol Use Disorder
Study Summary
This trial will study how well guanfacine works in treating stress and stimulation-based drinking behavior, and will compare how it affects men and women.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a male who drinks more than 14 drinks weekly and exceeds 4 drinks per day twice a week, or I am a female who drinks more than 7 drinks weekly and exceeds 3 drinks per day twice a week.I am between 21 and 70 years old.I can take pills and will follow the medication plan.I am not pregnant or nursing and use effective birth control or am surgically sterile/postmenopausal.I have not had any severe mental health issues like schizophrenia, bipolar disorder, major depression, or anxiety in the past 6 months.I don't have heart, liver, or kidney issues and haven't fainted or had a heart attack.I do not have any major health issues like heart problems, kidney or liver disease, seizures, or HIV.I can take pills and will follow the medication plan.I want to stop drinking alcohol completely.I have used drugs for mental health, like anxiety or depression meds, in the last 30 days.I am between 21 and 70 years old.You must be willing to drink less alcohol during the treatment period.You have been diagnosed with a drinking problem within the last 6 months.
- Group 1: Placebo
- Group 2: Guanfacine ER
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical research include participants who are of adult age?
"This research project stipulates that the minimum age for participation is 21 and no patient over 70 years old can join."
Has Guanfacine ER ever been the subject of prior clinical investigations?
"At the present time, there are 9 operational clinical trials analyzing Guanfacine ER with 2 of them in Phase 3. Although a portion of these tests for Guanfacine ER is taking place out of Palo Alto, California, there are 80 trial sites scattered across the nation."
Has Guanfacine ER been given clearance by the FDA?
"Evaluating the safety of Guanfacine ER, our team assigned a rating of 2. This is owing to the fact that this Phase 2 trial has accrued some data indicating its security but no evidence verifying efficacy yet."
What is the upper limit of individuals taking part in this investigation?
"Affirmative. The information presented on clinicaltrials.gov implies that this medical trial is being actively pursued, with the first post dated 8/10/2020 and the most recent update at 3/11/2022. 160 participants are required to be recruited from 1 site in total."
Is this a previously untested experiment?
"Since 2018, research has been conducted on Guanfacine ER. This medication was initially studied in a 20-person trial sponsored by Shire and following its success it received N/A drug approval. As of now, nine clinical studies are ongoing across 24 cities and nine different countries."
Am I eligible to participate in this research?
"To be considered for admission to this experiment, applicants must demonstrate drinking behavior and fall within the age demographic of 21-70. In total, 160 individuals will be admitted into the trial."
Are there still vacancies in this clinical experiment for participants?
"According to the clinicaltrials.gov database, this medical trial is actively searching for participants. It was initially posted on August 10th 2020 and most recently updated on March 11th 2022."
Share this study with friends
Copy Link
Messenger